Screening of Septo-optic Dysplasia During a Fetal Examination at 16-20 Weeks of Gestation
1 other identifier
interventional
52
1 country
1
Brief Summary
Evaluation of prenatal optic chiasm (OC) is important for the differential diagnosis of septo-optic dysplasia (SOD), which is a congenital optic disc anomaly, and the absence of the cavum septum pellucidum (CSP). Septo-optic dysplasia is associated with a wide range of neurological abnormalities, including hypoplasia of the visual pathways, CSP agenesis, and developmental delay.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 21, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 21, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 21, 2021
CompletedFirst Submitted
Initial submission to the registry
January 25, 2023
CompletedFirst Posted
Study publicly available on registry
February 8, 2023
CompletedFebruary 8, 2023
February 1, 2023
6 months
January 25, 2023
February 5, 2023
Conditions
Outcome Measures
Primary Outcomes (3)
Calculation of average width of OC according to gestational week in millimeter
2 months
Calculation of average height of OC according to gestational week in millimeter
2 months
Calculation of average area of OC according to gestational week millimeter square
2 months
Study Arms (1)
Screening septooptic dysplasia
OTHERDisplaying and measuring the width and length of the optic chiasm for screening septooptic dysplasia
Interventions
Displaying and measuring the width and length of the optic chiasm for screening septooptic dysplasia with ultrasound between 16-20 weeks of gestation
Eligibility Criteria
You may qualify if:
- aged greater than 18 years old
- having singleton pregnancy
You may not qualify if:
- being under the age of 18
- having IVF pregnancy
- having multiple pregnancy
- comorbidity during pregnancy
- smoking history
- presence of familial genetic disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gaziosmanpasa Training and Research Hospital
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
January 25, 2023
First Posted
February 8, 2023
Study Start
September 21, 2020
Primary Completion
March 21, 2021
Study Completion
April 21, 2021
Last Updated
February 8, 2023
Record last verified: 2023-02